Postoperative Residual Neuromuscular Blockade: A Continuing Patient Safety Issue

Scientific Programme – Symposium 2

Date: 20 May 2023, Saturday (GMT+8) | 20 May 2023, Friday (UTC-4) | 20 May 2023, Friday (UTC-5)
Time: 1445 – 1510 (GMT+8) | 0245 – 0310 (UTC-4) | 0145 – 0210 (UTC-5)

Speaker:


Tomoki Sasakawa MD

Abstract:

Considering the increasing use of sugammadex worldwide, we acknowledge the need to warn the medical community that the risk of recurarization is high in many parts of the world. We call for clinical attention to prevent recurarization, anaphylactic reactions, and other postoperative complications associated with using muscle relaxants and their antagonists based on neuromuscular monitoring.

More About Scientific Programme

SCIENTIFIC PROGRAMME

PLENARY 3
Blind Spot in Patient Safety – Safety II

by Della Lin MS, MD, FASA

With COVID-19, we saw a swift degradation of patient safety. This suggests that…

Read more

SCIENTIFIC PROGRAMME

SYMPOSIUM 3
Speaking Up Across Hierarchical Gradients: Overcoming the Barriers

by May Pian-Smith MD, MS

Dr. Pian-Smith’s research has focused on “speaking up” across hierarchical…

Read more

SCIENTIFIC PROGRAMME

SYMPOSIUM 3
The Ever-Changing Landscape of Non-Operating Room Anaesthesia: How to Overcome Potential Challenges in Ensuring Patient Safety?

by Richard D. Urman MD, MBA

Non-operating room anesthesia (NORA) has…

Read more